Langbahn Team – Weltmeisterschaft

LYB001

LYB001
Vaccine description
TargetSARS-CoV-2
Vaccine typeVirus-like particles
Clinical data
Routes of
administration
Intramuscular

LYB001 is a COVID-19 vaccine candidate developed by Yantai Patronus Biotech Co., Ltd.[1][2][3][4]

It was found to be safe and well tolerated.[5]

References